Search

everythinglearnresearchcommunity

for

Search:↓

New treatments like plant extracts, nanocarriers, and 3D bioprinting show promise for hair loss, but more research is needed.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

Oral tofacitinib effectively regrows hair in children with alopecia areata without major side effects.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Gut bacteria may influence hair loss in alopecia areata.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

DPCP can help regrow hair in some people with severe alopecia.

Shorter alopecia areata episodes lead to better baricitinib treatment outcomes.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

Exclamation mark hairs help distinguish syphilitic alopecia from alopecia areata.

Portraits show women's hairlines have moved forward over time, suggesting changes in the occurrence of frontal hair loss.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Both platelet-rich plasma and low-level laser therapy effectively treat hair loss with minimal side effects and good cost-benefit ratio.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Stem cell therapies show promise for hair regrowth in alopecia areata but need more research for safety and effectiveness.

Off-label treatments are heavily used for alopecia areata due to limited approved options.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

Alopecia areata patients need better education to improve their disease management.

Tofacitinib significantly regrows hair in severe alopecia without major side effects.

The Tru9I variant in the VDR gene may influence alopecia areata risk and vitamin D levels.

Most patients improved in both atopic dermatitis and alopecia areata with certain treatments, but some had worsened symptoms, suggesting personalized care is needed.

Vitamin D deficiency is common in children with and without alopecia areata, and more research is needed.

Baricitinib is effective for severe alopecia areata but has some side effects.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

The combined treatment helps improve severe hair loss and reduces the need for other medications.